Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-16-054824)

Filing Details

Accession Number:: 0001140361-16-054824
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-25 14:27:52
Reporting Period:: 2016-02-17

Filing Date:: 2016-02-25
Accepted Time:: 2016-02-25 14:27:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1094176	Anne M Szostak	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-02-17	2,000	$69.94	8,816	No	4	P	Indirect	M. Anne Szostak Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	M. Anne Szostak Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	584	Direct
Common Stock	6,600	Indirect	2014 Szostak IDEXX GRAT

Footnotes

The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $69.890 to $69.980, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.